Arbutus Biopharma Corporation (ABUS) Balance Sheet
As of 2026-06-30 (10-Q), Arbutus Biopharma Corporation (ABUS) reported total assets of $274.0M, total liabilities of $15.3M and shareholders' equity of $258.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $19.2M. Long-term debt: $0.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ABUSArbutus Biopharma CorporationFollow ABUS — free
—
Price chart with a free account
- Market cap
- 831.0M
- P/E TTM
- 5.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 72.2 | 166.8 | 23.4 | 54.3 | 36.9 | 31.8 | 52.3 | 109.3 | 30.8 | 26.3 | 36.3 | 18.0 | 19.2 | |
| Short-term investments | 40.0 | 14.5 | 107.1 | 72.1 | 87.7 | 59.0 | 71.0 | 46.0 | 116.1 | 99.7 | 86.3 | 73.5 | 73.5 | |
| Receivables | 1.9 | 1.0 | 0.3 | 0.4 | 1.4 | 1.2 | 1.3 | 0.9 | 1.4 | 1.8 | 2.4 | 1.4 | 0.4 | |
| Current assets | 116.4 | 183.9 | 132.6 | 129.4 | 129.2 | 93.8 | 127.7 | 160.7 | 151.1 | 132.0 | 127.3 | 94.5 | 273.9 | |
| Total assets | 118.2 | 712.3 | 275.9 | 237.2 | 227.9 | 105.5 | 137.1 | 204.5 | 195.4 | 144.4 | 131.7 | 94.6 | 274.0 | |
| Current liabilities | 20.2 | 10.6 | 10.6 | 14.6 | 11.2 | 7.8 | 9.5 | 11.2 | 32.9 | 22.5 | 15.6 | 6.0 | 3.4 | |
| Long-term debt | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total liabilities | 30.1 | 164.6 | 72.9 | 54.7 | 27.7 | 32.8 | 35.1 | 35.0 | 58.6 | 38.4 | 34.3 | 18.0 | 15.3 | |
| Shareholders' equity | 88.0 | 547.7 | 203.0 | 182.5 | 200.2 | 72.7 | 102.0 | 169.4 | 136.9 | 106.0 | 97.4 | 76.6 | 258.7 |
USD millions · SEC XBRL
Arbutus Biopharma Corporation — questions
- How much cash does Arbutus Biopharma Corporation have?
- $19.2M in cash and cash equivalents as of 2026-06-30.
- How much debt does Arbutus Biopharma Corporation have?
- $0 of long-term debt as of 2026-06-30.
- What are Arbutus Biopharma Corporation's total assets?
- $274.0M as of 2026-06-30.
- What is Arbutus Biopharma Corporation's shareholders' equity?
- $258.7M as of 2026-06-30.
Every figure on this page comes from Arbutus Biopharma Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.